These 3 Stocks Have a Killer Advantage

These 3 Stocks Have a Killer Advantage

The following stocks have a formidable moats amid next-gen technologies, making them strong outperformers in 2020. The technology hardware business has a reputation for being very cyclical and economically sensitive. However, the following three stocks — Taiwan Semiconductor Manufacturing (NYSE:TSM), ASML Holdings (NASDAQ:ASML), and NVIDIA (NASDAQ:NVDA) — have all absolutely trounced the market this year,…

Read more
Microsoft’s Big Game Plan with Teams

Microsoft’s Big Game Plan with Teams

Microsoft’s hottest product in years is also one the software giant gives away for free. It has its reasons. The coronavirus pandemic that has kept so many office workers at home since March has also made a fresh case for Teams, Microsoft’s package of workplace collaboration tools that compete with services like Slack, Dropbox and…

Read more
Noble Energy, Disney, Facebook, AstraZeneca

Noble Energy, Disney, Facebook, AstraZeneca

Here are five things you must know for Monday, July 20:1. — Stock Futures Dip as Wall Street Turns Eye to Earnings ReportsStock futures were mostly lower Monday as Wall Street came off its third straight week of gains and investors turned their attention to a flurry of earnings reports.Contracts linked to the Dow Jones…

Read more
Why the next decade of stock market returns could blow away expectations: Morning Brief

Why the next decade of stock market returns could blow away expectations: Morning Brief

Monday, July 20, 2020Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET. SubscribeS&P 500 turnover is unpredictable in a bullish wayCould the stock market deliver extraordinary returns over the next decade?As we’ve written before, some of the more widely-followed stock market forecasters believe the average annual total return…

Read more
British pharma firm claims small trial on a coronavirus treatment could signal ‘major breakthrough’

British pharma firm claims small trial on a coronavirus treatment could signal ‘major breakthrough’

British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized Covid-19 patients needing intensive care in a clinical trial.The company said its nebulizer treatment produced a 79% lower risk of patients developing severe disease than those given a placebo in initial trials, and patients that received the…

Read more